Mutual of America Capital Management LLC Has $5.47 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Mutual of America Capital Management LLC increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 117.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,757 shares of the medical technology company’s stock after acquiring an additional 16,629 shares during the quarter. Mutual of America Capital Management LLC owned about 0.07% of Teleflex worth $5,474,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Apollon Wealth Management LLC lifted its stake in shares of Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after acquiring an additional 55 shares during the period. SRS Capital Advisors Inc. lifted its stake in Teleflex by 0.3% in the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 60 shares during the period. Janney Montgomery Scott LLC lifted its stake in Teleflex by 0.4% in the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after buying an additional 65 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its stake in Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after buying an additional 66 shares during the period. Finally, HighTower Advisors LLC lifted its stake in Teleflex by 1.7% in the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after buying an additional 66 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Up 1.9 %

NYSE TFX opened at $135.31 on Tuesday. The firm has a market cap of $6.28 billion, a P/E ratio of 26.90, a P/E/G ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock’s 50-day moving average is $174.58 and its 200-day moving average is $203.93. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.90.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.01%. Teleflex’s payout ratio is presently 95.77%.

Wall Street Analyst Weigh In

TFX has been the topic of several analyst reports. Truist Financial cut their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday. Piper Sandler reissued a “neutral” rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Nine analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $188.33.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.